Table 2.
Demographic and clinical characteristics (N = 764).
| N | % | Mean | SD | |
|---|---|---|---|---|
| Age (y) | 764 | – | 67.9 | 15.8 |
| Female | 397 | 52.0 | – | – |
| African-American | 210 | 27.5 | – | – |
| Caucasian | 481 | 63.0 | – | – |
| Asian | 12 | 1.6 | – | – |
| American Indian or Alaskan Native | 10 | 1.3 | – | – |
| Other race | 25 | 3.3 | – | – |
| Hypertension | 587 | 76.8 | – | – |
| Hyperlipidemia | 360 | 47.1 | – | – |
| Diabetes | 216 | 28.3 | – | – |
| Coronary artery disease | 17 | 2.2 | – | – |
| Atrial fibrillation | 218 | 28.5 | – | – |
| Smoking | 269 | 35.2 | – | – |
| Previous ischemic stroke | 173 | 22.6 | – | – |
| Obesity | 290 | 38.0 | – | – |
| Presenting glucose (mg/dL) | – | – | 139.7 | 56.9 |
| Presented in 0–6 h window | 550 | 72.0 | – | – |
| Presented in 6–16 h window | 172 | 22.5 | – | – |
| Presented in 16–24 h window | 42 | 5.5 | – | – |
| CTP completed | 592 | 77.5 | – | – |
| No EVT | 369 | 48.3 | – | – |
| EVT only | 202 | 26.4 | – | – |
| IV TPA and EVT | 193 | 25.3 | – | – |
SD Standard deviation, EVT Endovascular therapy, IV TPA Intravenous tissue plasminogen activator, CTP Computed tomography perfusion.